Elmien Bronkhorst
Overview
Explore the profile of Elmien Bronkhorst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bronkhorst E, Maboa R, Skosana P
JAC Antimicrob Resist
. 2025 Mar;
7(2):dlaf025.
PMID: 40046069
Introduction: Antimicrobial resistance, and specifically carbapenem resistance, have developed into a major challenge globally. Because carbapenems are used increasingly as empirical treatment in the presence of rising ESBL infection, the...
2.
Crafford L, Kusurkar R, Bronkhorst E, Gous A, Wouters A
BMC Med Educ
. 2024 Oct;
24(1):1179.
PMID: 39434067
Background: While multidisciplinary teams with clinical pharmacists improve medication use and outcomes, their integration in South Africa faces limitations. A lack of dedicated positions and healthcare professionals' misunderstanding restrict ward...
3.
Bronkhorst E, Joseph-Busby M, Bezuidenhout S
South Afr J HIV Med
. 2024 Sep;
25(1):1594.
PMID: 39228916
Background: The roll-out of antiretroviral medicines has improved life expectancy in people living with HIV (PLHIV). This has resulted in more patients being hospitalised for non-communicable diseases, increasing risk for...
4.
Bronkhorst E, Adamjee M, Poka M
S Afr Fam Pract (2004)
. 2024 Jun;
66(1):e1-e7.
PMID: 38832385
Background: Pharmacy professionals working in community pharmacies frequently provide pharmacist-initiated therapy, including codeine-containing medicines. Codeine is an opioid with great potential for misuse, adding to the global opioid epidemic burden....
5.
Bronkhorst E, Hattingh S, Poka M
Health SA
. 2024 Apr;
28:2135.
PMID: 38633911
Background: South Africa has the highest prevalence of people living with HIV globally. Although antiretroviral therapy provides solutions, evidence of antiretroviral resistance emerged, requiring the application of antiretroviral-stewardship programmes to...
6.
Bopape P, Wagenaar C, Poka M, Bronkhorst E
S Afr Fam Pract (2004)
. 2023 Nov;
65(1):e1-e6.
PMID: 37916701
Vitamin D is a fat-soluble molecule referring to the different isoforms, ergocalciferol (D2) and cholecalciferol (D3). Its physiological functions include increasing calcium serum concentrations. 25-hydroxyvitamin D3 (25(OH)D) (Calcifediol), a non-active,...
7.
Schellack N, Strydom M, Pepper M, Herd C, Hendricks C, Bronkhorst E, et al.
Antibiotics (Basel)
. 2022 Apr;
11(4).
PMID: 35453198
The capacity for social media to influence the utilization of re-purposed medicines to manage COVID-19, despite limited availability of safety and efficacy data, is a cause for concern within health...
8.
Mokwele R, Schellack N, Bronkhorst E, Brink A, Schweickerdt L, Godman B
JAC Antimicrob Resist
. 2022 Feb;
4(1):dlab196.
PMID: 35146427
Background: Inappropriate use of antimicrobials is a key factor increasing antimicrobial resistance, a major global public health problem including in South Africa. Key drivers include antibiotics being dispensed without a...
9.
Bronkhorst E, Schellack N, Gous A
Front Pharmacol
. 2021 Dec;
12:734654.
PMID: 34925004
The National Department of Health published their Quality Standards for Healthcare Establishments in South Africa and introduced the National Health Insurance, with the pilot phase that commenced in 2012. The...
10.
Crafford L, Wouters A, Bronkhorst E, Gous A, Kusurkar R
Front Med (Lausanne)
. 2021 Dec;
8:747348.
PMID: 34888322
Pharmacy practice in many middle to low-income countries has slowly transitioned from being product-focused to a more patient-focused clinical practice. Lack of motivation is one of the factors contributing to...